Clinical Study

Efficacy and Side Effects of Narrowband-UVB in Early Stage Cutaneous T-Cell Lymphoma in Jordanian Patients

Table 2

Rates of complete remission, number of treatment sessions, and NB-UVB dose in relation to skin phototype.

Skin type IIISkin type IVSkin type V

Complete remission: % (number) 81.2 (13/16)71.4 (5/7)75 (3/4)
Number of sessions: range (mean)15–34 (24.7)16–39 (32.2)19–42 (36.7)
NB-UVB dose in J/cm2:
range (mean)
17.2–36.3 (37.1) 19.7–42.1 (39.1) 20.9–48.2 (44.3)